ACRO Biomedical Company

About ACRO Biomedical Company
ACRO Biomedical was founded in 2014 in Kaohsiung, Taiwan by Dar-Jen Hsieh, PhD, and a group of scientists and physicians.
ACRO is the leader in the field of collagen-derived medical devices, which are produced by its proprietary supercritical CO2 extraction technology to remove lipids, cells and non-collagenous proteins from tissues and organs to create natural collagen scaffolds suitable as xenograft biomaterials for human tissue engineering and regenerative medicine applications. 

CEO, Dar-Jen Hsieh (PHD '94)